[1]
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England). 2018 Nov 10:392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8
[PubMed PMID: 30496104]
Level 1 (high-level) evidence
[2]
Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Current opinion in rheumatology. 2018 Mar:30(2):160-167. doi: 10.1097/BOR.0000000000000479. Epub
[PubMed PMID: 29227353]
Level 3 (low-level) evidence
[3]
Rego-Pérez I, Durán-Sotuela A, Ramos-Louro P, Blanco FJ. Mitochondrial Genetics and Epigenetics in Osteoarthritis. Frontiers in genetics. 2019:10():1335. doi: 10.3389/fgene.2019.01335. Epub 2020 Jan 17
[PubMed PMID: 32010192]
[4]
Yip C, Badley EM, Canizares M, Power JD, Perruccio AV. Risk Factor Profiles for Individuals With Diagnosed OA and With Symptoms Indicative of OA: Findings From the Canadian Longitudinal Study on Aging. ACR open rheumatology. 2020 Mar:2(3):174-179. doi: 10.1002/acr2.11120. Epub 2020 Mar 1
[PubMed PMID: 32114717]
[5]
Allen KD, Golightly YM. State of the evidence. Current opinion in rheumatology. 2015 May:27(3):276-83. doi: 10.1097/BOR.0000000000000161. Epub
[PubMed PMID: 25775186]
Level 3 (low-level) evidence
[6]
Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best practice & research. Clinical rheumatology. 2014 Feb:28(1):5-15. doi: 10.1016/j.berh.2014.01.004. Epub
[PubMed PMID: 24792942]
[7]
Khlopas H, Khlopas A, Samuel LT, Ohliger E, Sultan AA, Chughtai M, Mont MA. Current Concepts in Osteoarthritis of the Ankle: Review. Surgical technology international. 2019 Nov 10:35():280-294
[PubMed PMID: 31237341]
[8]
Sulzbacher I. Osteoarthritis: histology and pathogenesis. Wiener medizinische Wochenschrift (1946). 2013 May:163(9-10):212-9. doi: 10.1007/s10354-012-0168-y. Epub 2012 Dec 20
[PubMed PMID: 23263638]
[9]
Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L, Suarez-Almazor M, Gooberman-Hill R. Understanding the pain experience in hip and knee osteoarthritis--an OARSI/OMERACT initiative. Osteoarthritis and cartilage. 2008 Apr:16(4):415-22. doi: 10.1016/j.joca.2007.12.017. Epub 2008 Mar 4
[PubMed PMID: 18296075]
Level 3 (low-level) evidence
[10]
Allen KD, Coffman CJ, Golightly YM, Stechuchak KM, Keefe FJ. Daily pain variations among patients with hand, hip, and knee osteoarthritis. Osteoarthritis and cartilage. 2009 Oct:17(10):1275-82. doi: 10.1016/j.joca.2009.03.021. Epub 2009 Apr 17
[PubMed PMID: 19410670]
[11]
Peter JB, Marmor L. Osteoarthritis of the first carpometacarpal joint. California medicine. 1968 Aug:109(2):116-20
[PubMed PMID: 5673986]
[12]
Hosnijeh FS, Runhaar J, van Meurs JB, Bierma-Zeinstra SM. Biomarkers for osteoarthritis: Can they be used for risk assessment? A systematic review. Maturitas. 2015 Sep:82(1):36-49. doi: 10.1016/j.maturitas.2015.04.004. Epub 2015 Apr 14
[PubMed PMID: 25963100]
Level 1 (high-level) evidence
[13]
Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, Herrero-Beaumont G, Kirschner S, Leeb BF, Lohmander LS, Mazières B, Pavelka K, Punzi L, So AK, Tuncer T, Watt I, Bijlsma JW. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Annals of the rheumatic diseases. 2010 Mar:69(3):483-9. doi: 10.1136/ard.2009.113100. Epub 2009 Sep 17
[PubMed PMID: 19762361]
[14]
Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, Dincer F, Dziedzic K, Hauselmann HJ, Kaklamanis P, Kloppenburg M, Lohmander LS, Maheu E, Martin-Mola E, Pavelka K, Punzi L, Reiter S, Smolen J, Verbruggen G, Watt I, Zimmermann-Gorska I, ESCISIT. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Annals of the rheumatic diseases. 2009 Jan:68(1):8-17. doi: 10.1136/ard.2007.084772. Epub 2008 Feb 4
[PubMed PMID: 18250111]
[15]
Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology (Oxford, England). 2018 May 1:57(suppl_4):iv51-iv60. doi: 10.1093/rheumatology/kex501. Epub
[PubMed PMID: 29351654]
[16]
Ton J, Perry D, Thomas B, Allan GM, Lindblad AJ, McCormack J, Kolber MR, Garrison S, Moe S, Craig R, Dugré N, Chan K, Finley CR, Ting R, Korownyk CS. PEER umbrella systematic review of systematic reviews: Management of osteoarthritis in primary care. Canadian family physician Medecin de famille canadien. 2020 Mar:66(3):e89-e98
[PubMed PMID: 32165479]
Level 1 (high-level) evidence
[17]
Barrow DR, Abbate LM, Paquette MR, Driban JB, Vincent HK, Newman C, Messier SP, Ambrose KR, Shultz SP. Exercise prescription for weight management in obese adults at risk for osteoarthritis: synthesis from a systematic review. BMC musculoskeletal disorders. 2019 Dec 20:20(1):610. doi: 10.1186/s12891-019-3004-3. Epub 2019 Dec 20
[PubMed PMID: 31861990]
Level 1 (high-level) evidence
[18]
Leopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, Hunter DJ, Ferreira ML. Paracetamol versus placebo for knee and hip osteoarthritis. The Cochrane database of systematic reviews. 2019 Feb 25:2(2):CD013273. doi: 10.1002/14651858.CD013273. Epub 2019 Feb 25
[PubMed PMID: 30801133]
Level 1 (high-level) evidence
[19]
Charlesworth J, Fitzpatrick J, Perera NKP, Orchard J. Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee. BMC musculoskeletal disorders. 2019 Apr 9:20(1):151. doi: 10.1186/s12891-019-2525-0. Epub 2019 Apr 9
[PubMed PMID: 30961569]
Level 1 (high-level) evidence
[20]
Hussain S, Singh A, Akhtar M, Najmi AK. Vitamin D supplementation for the management of knee osteoarthritis: a systematic review of randomized controlled trials. Rheumatology international. 2017 Sep:37(9):1489-1498. doi: 10.1007/s00296-017-3719-0. Epub 2017 Apr 18
[PubMed PMID: 28421358]
Level 1 (high-level) evidence
[21]
Stewart M, Cibere J, Sayre EC, Kopec JA. Efficacy of commonly prescribed analgesics in the management of osteoarthritis: a systematic review and meta-analysis. Rheumatology international. 2018 Nov:38(11):1985-1997. doi: 10.1007/s00296-018-4132-z. Epub 2018 Aug 17
[PubMed PMID: 30120508]
Level 1 (high-level) evidence
[23]
Toupin April K, Bisaillon J, Welch V, Maxwell LJ, Jüni P, Rutjes AW, Husni ME, Vincent J, El Hindi T, Wells GA, Tugwell P. Tramadol for osteoarthritis. The Cochrane database of systematic reviews. 2019 May 27:5(5):CD005522. doi: 10.1002/14651858.CD005522.pub3. Epub 2019 May 27
[PubMed PMID: 31132298]
Level 1 (high-level) evidence
[24]
Jüni P, Hari R, Rutjes AW, Fischer R, Silletta MG, Reichenbach S, da Costa BR. Intra-articular corticosteroid for knee osteoarthritis. The Cochrane database of systematic reviews. 2015 Oct 22:2015(10):CD005328. doi: 10.1002/14651858.CD005328.pub3. Epub 2015 Oct 22
[PubMed PMID: 26490760]
Level 1 (high-level) evidence
[25]
Zhong HM, Zhao GF, Lin T, Zhang XX, Li XY, Lin JF, Zhao SQ, Pan ZJ. Intra-Articular Steroid Injection for Patients with Hip Osteoarthritis: A Systematic Review and Meta-Analysis. BioMed research international. 2020:2020():6320154. doi: 10.1155/2020/6320154. Epub 2020 Feb 24
[PubMed PMID: 32185212]
Level 1 (high-level) evidence
[26]
Xing D, Wang B, Liu Q, Ke Y, Xu Y, Li Z, Lin J. Intra-articular Hyaluronic Acid in Treating Knee Osteoarthritis: a PRISMA-Compliant Systematic Review of Overlapping Meta-analysis. Scientific reports. 2016 Sep 12:6():32790. doi: 10.1038/srep32790. Epub 2016 Sep 12
[PubMed PMID: 27616273]
Level 1 (high-level) evidence
[27]
Chen Z, Wang C, You D, Zhao S, Zhu Z, Xu M. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis. Medicine. 2020 Mar:99(11):e19388. doi: 10.1097/MD.0000000000019388. Epub
[PubMed PMID: 32176063]
Level 1 (high-level) evidence
[28]
Hohmann E, Tetsworth K, Glatt V. Is platelet-rich plasma effective for the treatment of knee osteoarthritis? A systematic review and meta-analysis of level 1 and 2 randomized controlled trials. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie. 2020 Aug:30(6):955-967. doi: 10.1007/s00590-020-02623-4. Epub 2020 Feb 14
[PubMed PMID: 32060630]
Level 1 (high-level) evidence
[29]
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and cartilage. 2008 Feb:16(2):137-62. doi: 10.1016/j.joca.2007.12.013. Epub
[PubMed PMID: 18279766]
Level 3 (low-level) evidence
[30]
Stoffer-Marx MA, Klinger M, Luschin S, Meriaux-Kratochvila S, Zettel-Tomenendal M, Nell-Duxneuner V, Zwerina J, Kjeken I, Hackl M, Öhlinger S, Woolf A, Redlich K, Smolen JS, Stamm TA. Functional consultation and exercises improve grip strength in osteoarthritis of the hand - a randomised controlled trial. Arthritis research & therapy. 2018 Nov 9:20(1):253. doi: 10.1186/s13075-018-1747-0. Epub 2018 Nov 9
[PubMed PMID: 30413191]
Level 1 (high-level) evidence
[31]
Marshall M, Watt FE, Vincent TL, Dziedzic K. Hand osteoarthritis: clinical phenotypes, molecular mechanisms and disease management. Nature reviews. Rheumatology. 2018 Nov:14(11):641-656. doi: 10.1038/s41584-018-0095-4. Epub
[PubMed PMID: 30305701]
[32]
Lue S, Koppikar S, Shaikh K, Mahendira D, Towheed TE. Systematic review of non-surgical therapies for osteoarthritis of the hand: an update. Osteoarthritis and cartilage. 2017 Sep:25(9):1379-1389. doi: 10.1016/j.joca.2017.05.016. Epub 2017 Jun 15
[PubMed PMID: 28602781]
Level 1 (high-level) evidence
[33]
Apold H, Meyer HE, Nordsletten L, Furnes O, Baste V, Flugsrud GB. Risk factors for knee replacement due to primary osteoarthritis, a population based, prospective cohort study of 315,495 individuals. BMC musculoskeletal disorders. 2014 Jun 23:15():217. doi: 10.1186/1471-2474-15-217. Epub 2014 Jun 23
[PubMed PMID: 24957045]
[34]
Brosseau L, Thevenot O, MacKiddie O, Taki J, Wells GA, Guitard P, Léonard G, Paquet N, Aydin SZ, Toupin-April K, Cavallo S, Moe RH, Shaikh K, Gifford W, Loew L, De Angelis G, Shallwani SM, Aburub AS, Mizusaki Imoto A, Rahman P, Álvarez Gallardo IC, Cosic MB, Østerås N, Lue S, Hamasaki T, Gaudreault N, Towheed TE, Koppikar S, Kjeken I, Mahendira D, Kenny GP, Paterson G, Westby M, Laferrière L, Longchamp G. The Ottawa Panel guidelines on programmes involving therapeutic exercise for the management of hand osteoarthritis. Clinical rehabilitation. 2018 Nov:32(11):1449-1471. doi: 10.1177/0269215518780973. Epub 2018 Jun 18
[PubMed PMID: 29911409]
[35]
Gwynne-Jones DP, Gray AR, Hutton LR, Stout KM, Abbott JH. Outcomes and Factors Influencing Response to an Individualized Multidisciplinary Chronic Disease Management Program for Hip and Knee Osteoarthritis. The Journal of arthroplasty. 2018 Sep:33(9):2780-2786. doi: 10.1016/j.arth.2018.04.011. Epub 2018 Apr 16
[PubMed PMID: 29739632]
[36]
Kuijpers MFL, Hannink G, van Steenbergen LN, Schreurs BW. Total Hip Arthroplasty in Young Patients in The Netherlands: Trend Analysis of }19,000 Primary Hip Replacements in the Dutch Arthroplasty Register. The Journal of arthroplasty. 2018 Dec:33(12):3704-3711. doi: 10.1016/j.arth.2018.08.020. Epub 2018 Aug 22
[PubMed PMID: 30217401]
[37]
Loures FB, Correia W, Reis JH, Pires E Albuquerque RS, de Paula Mozela A, de Souza EB, Maia PV, Barretto JM. Outcomes after knee arthroplasty in extra-articular deformity. International orthopaedics. 2019 Sep:43(9):2065-2070. doi: 10.1007/s00264-018-4147-9. Epub 2018 Sep 14
[PubMed PMID: 30215100]